Evidence map›Paper›PMID 41125372›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient.

Kaito Harada, Shino Iwata, Shinichiro Machida, Daisuke Furuya, Sawako Shiraiwa, Yasuyuki Aoyama, Hiroki Numata, Sakura Tomita, Rikio Suzuki, Masako Toyosaki and 5 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kaito HaradaDepartment of Hematology, Ebina General Hospital, Japan.
Shino IwataDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.
Shinichiro MachidaDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.
Daisuke FuruyaDepartment of Hematology, Ebina General Hospital, Japan.
Sawako ShiraiwaDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.
Yasuyuki AoyamaDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.
Hiroki NumataDepartment of Hematology, Ebina General Hospital, Japan.
Sakura TomitaDepartment of Pathology, Tokai University School of Medicine, Japan.
Rikio SuzukiDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.
Masako ToyosakiDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.
Ai KotaniDepartment of Hematological Malignancy, Institute of Medical Science, Tokai University, Japan.
Yoshiaki OgawaDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.
Hiroshi KawadaDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.
Naoya NakamuraDepartment of Pathology, Tokai University School of Medicine, Japan.
Makoto OnizukaDepartment of Hematology and Oncology, Tokai University School of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic active Epstein-Barr virus (CAEBV) infection is a rare and potentially fatal condition involving EBV-infected T or natural killer cells. We herein report a 46-year-old man with CAEBV complicated by cardiomyopathy. Imaging and a biopsy revealed EBV-positive CD3

Indexed as

CardiomyopathiesEpstein-Barr Virus InfectionsChronic DiseaseCord Blood Stem Cell TransplantationCytarabineHerpesvirus 4, HumanHumansMaleMiddle AgedTreatment OutcomeCytarabinechronic active Epstein-Barr viruscord blood transplantationendomyocardial biopsy

Identifiers

PMID41125372
PMCPMC13294587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.